Accessibility Menu
 
Bioxytran logo

Bioxytran

(OTC) BIXT

Current Price$0.04
Market Cap$4.81M
Since IPO (2018)-84%
5 Year-70%
1 Year-72%
1 Month+8%

Bioxytran Financials at a Glance

Market Cap

$4.81M

Revenue (TTM)

$0.00

Net Income (TTM)

$2.11M

EPS (TTM)

$-0.02

P/E Ratio

-2.03

Dividend

$0.00

Beta (Volatility)

2.39 (High)

Price

$0.04

Volume

7,000

Open

$0.04

Previous Close

$0.05

Daily Range

$0.04 - $0.04

52-Week Range

$0.03 - $0.23

BIXT News

No articles available.

BIXT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bioxytran

Industry

Biotechnology

Employees

3

CEO

David Platt, PhD

Headquarters

Newton, MA 02464, US

BIXT Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

59%

Return on Assets

-14%

Earnings Yield

-49.26%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.81M

Shares Outstanding

98.90M

Volume

7.00K

Short Interest

0.00%

Avg. Volume

398.52K

Financials (TTM)

Gross Profit

$7.95K

Operating Income

$2.22M

EBITDA

$2.22M

Operating Cash Flow

$55.74K

Capital Expenditure

$28.20K

Free Cash Flow

$83.93K

Cash & ST Invst.

$5.15K

Total Debt

$1.09M

Bioxytran Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$4.24K

-179.4%

Gross Margin

0.00%

N/A

Market Cap

$4.81M

N/A

Market Cap/Employee

$1.60M

N/A

Employees

3

N/A

Net Income

$282.73K

+27.9%

EBITDA

$241.97K

+30.1%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$840.50K

+6.5%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$855.00K

-8.4%

Return on Assets

-13.52%

N/A

Return on Invested Capital

59.18%

N/A

Free Cash Flow

$26.32K

-224.4%

Operating Cash Flow

$41.47K

-229.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CPMVMosaic ImmunoEngineering Inc.
$0.69+0.00%
KNBIFKane Biotech Inc.
$0.02+0.00%
BZYRBurzynski Research Institute, Inc.
$0.02+0.00%
GLWLFGlow Lifetech Corp.
$0.04-2.58%

Trending Stocks

Symbol / CompanyPricePrice Chg
TERNTerns Pharmaceuticals
$52.76+0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.29-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$44.28+0.02%
UGROUrban-gro
$13.92+0.98%

Questions About BIXT

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.